BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform

· Financial Post

Collaboration builds on CAR-T commercialization in New Zealand and supports expansion across Australia, North America and other international markets Read More

Visit somethingsdifferent.biz for more information.

Read full story at source